Evidence map›Paper›PMID 29080008›Full record

ArticleLasers in medical science2018

Objective evaluation of the efficacy of a non-ablative fractional 1565 nm laser for the treatment of deliberate self-harm scars.

Anne Guertler, Markus Reinholz, Julian Poetschke, Stephanie Steckmeier, Hannah Schwaiger, Gerd G Gauglitz

Registry-linked trialAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Lasers in medical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04237324 (A Prospective, Randomized Controlled Split-face Trial of a Fractional Microneedle Radiofrequency Device(FMR) and Fractional Erbium-Doped Glass 1,565-nm Device), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04237324 naunknown statusnot on this map

A Prospective, Randomized Controlled Split-face Trial of a Fractional Microneedle Radiofrequency Device(FMR) and Fractional Erbium-Doped Glass 1,565-nm Device(NAFL) Therapy in Baggy Lower Eyelids

TypeinterventionalSponsorXijing HospitalRan2018 to 2021Enrolled15ConditionsPhotoagingArmsTreatment one side BLE by NAFL, Treatment another side BLE by FMR
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Sequential Fractional COJournal of clinical medicine · 2025
    Review
  4. Scars.Nature reviews. Disease primers · 2023
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anne GuertlerClinic of Dermatology and Allergy, Department for Aesthetic Dermatology and Laser Medicine, Ludwig Maximilian University, Frauenlobstr. 9-11, 80337, Munich, Germany. a.guertler@med.uni-muenchen.de.ORCID http://orcid.org/0000-0001-6865-0526
Markus ReinholzClinic of Dermatology and Allergy, Department for Aesthetic Dermatology and Laser Medicine, Ludwig Maximilian University, Frauenlobstr. 9-11, 80337, Munich, Germany.
Julian PoetschkeDepartment for Plastic and Handsurgery, Regional Burn Center, Klinikum St. Georg, 04129, Leipzig, Germany.
Stephanie SteckmeierClinic of Dermatology and Allergy, Department for Aesthetic Dermatology and Laser Medicine, Ludwig Maximilian University, Frauenlobstr. 9-11, 80337, Munich, Germany.
Hannah SchwaigerClinic of Dermatology and Allergy, Department for Aesthetic Dermatology and Laser Medicine, Ludwig Maximilian University, Frauenlobstr. 9-11, 80337, Munich, Germany.
Gerd G GauglitzClinic of Dermatology and Allergy, Department for Aesthetic Dermatology and Laser Medicine, Ludwig Maximilian University, Frauenlobstr. 9-11, 80337, Munich, Germany.
Ludwig-Maximilians-Universität München · DEKlinikum St. Georg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scars resulting from deliberate self-harm (DSH) represent therapeutically challenging forms of scarring due to their highly variable patterns, with no official therapeutic guidelines available. In this pilot study, we aimed to evaluate the effectiveness and safety of a non-ablative fractional Er:glass 1565 nm laser, as a potential new, minimal-invasive approach for the improvement of DSH scars. Sixteen Caucasians suffering from mature DSH scars were included in this clinical study. Patients received a total of three treatments using a non-ablative fractional 1565 nm Er:glass laser every 4 weeks, employing two passes (300 μbeams/cm

Indexed as

AdultCicatrixFemaleHumansLasers, Solid-StateLaser TherapyMaleMiddle AgedPilot ProjectsQuality of LifeSelf-Injurious BehaviorSkinSurveys and QuestionnairesTreatment OutcomeYoung Adult1565 nmDeliberate self-harmDSHLaser treatmentNon-ablative fractionalScar

Identifiers

PMID29080008
OpenAlexW2765708862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.